CROSSWORD - CURRENT TREND

12345678
Across
  1. 2. As an adjuvant only in moderate to severe COVID - 19 patients.
  2. 3. For the treatment of schizophrenia in adults.
  3. 5. Recent bio similar for rituximab.
  4. 7. For the treatment of uncomplicated UTI.
  5. 8. Antifibrinolytic agent approved for idiopathic pulonary fibrosis.
Down
  1. 1. Endocrine therapy for adjuvant treatment of HR positive, HER-2 negative, node positive, early breast cancer at high risk of recurrence.
  2. 4. For the treatment of latent TB causing Mycobacterium tuberculosis.
  3. 6. For the treatment of neurofibromatosis type I in paediatric (> 3 years) and adults.